Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff
- PMID: 23090591
- PMCID: PMC3869186
- DOI: 10.1007/s13187-012-0427-z
Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff
Abstract
This paper describes the development and initial evaluation of a didactic curriculum to prepare research support staff with the core knowledge and skills required to collect patient-reported outcomes (PROs) via interviews. Research support staff members (N = 77) were recruited for eight separate workshops, each consisting of a didactic presentation followed by role-play scenarios with trained actors depicting common scenarios they may encounter as part of patient interaction. Trainees were observed and received feedback on their performance from trained facilitators and peers. In comparison to their pre-training assessment, trainees showed significant improvement in their confidence to conduct a research interview, handle a distressed participant, manage a wandering interview, ask participants sensitive questions, and handle irritated patients. Training research support staff in the effective collection of PROs via patient interviews can improve the confidence of these individuals in interacting with patients, which can ultimately lead to increased accuracy of data collection.
Conflict of interest statement
There are no financial relationships associated with these results that may reflect a conflict of interest or be perceived to reflect a conflict of interest.
References
-
- Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007;25:5374–5380. - PubMed
-
- NCI; National Cancer Institute. NCI Guidelines - Expedited adverse event reporting requirements for NCI investigational agents. Bethesda: National Cancer Institute; 2001. Cancer Therapy Evaluation Program.
-
- US Food and Drug Administration. Guidance for Industry. [Accessed June 14, 2012];Patient-reported outcome measures: Use in medical development to support labeling claims. 2009 Dec; Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous